Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroprocaine 3% gel vs tetracaine 0.5% eye drops for topical anesthesia in phacoemulsification
2019-001660-30Phase 3Completed
- Sponsor
- Sintetica
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of chloroprocaine in cataract (2 arms), sponsored by Sintetica. Primary endpoint: Successful surface anesthesia without supplementation at T4. Started Mar 2020; status: completed.
02
Drugs
chloroprocaine
03
Conditions
cataract
Beyond the preview
Go deeper on 2019-001660-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001660-30.